Laranjo, Jean D.
HRN: 22-77-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2023
METRONIDAZOLE 500MG (TAB)
03/24/2023
03/24/2023
PO
500mg
TID
Thickly Msaf
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes